AAM
Azzad Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,553
| Closed | -$223K | – | 396 |
|
|
2022
Q1 | $223K | Buy |
3,553
+545
| +18% | +$34.2K | 0.03% | 314 |
|
|
2021
Q4 | $228K | Buy |
3,008
+151
| +5% | +$11.4K | 0.03% | 317 |
|
|
2021
Q3 | $320K | Sell |
2,857
-63
| -2% | -$7.05K | 0.05% | 305 |
|
|
2021
Q2 | $473K | Buy |
2,920
+48
| +2% | +$7.77K | 0.07% | 287 |
|
|
2021
Q1 | $350K | Buy |
+2,872
| New | +$350K | 0.06% | 287 |
|